Abbott India Past Earnings Performance

Past criteria checks 6/6

Abbott India has been growing earnings at an average annual rate of 17.5%, while the Pharmaceuticals industry saw earnings growing at 15.5% annually. Revenues have been growing at an average rate of 9.3% per year. Abbott India's return on equity is 32.5%, and it has net margins of 20.5%.

Key information

17.5%

Earnings growth rate

17.5%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate9.3%
Return on equity32.5%
Net Margin20.5%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Abbott India makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:500488 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2458,48912,0126,9100
31 Dec 2357,53411,4566,7990
30 Sep 2356,38410,8146,7600
30 Jun 2355,23610,3406,8280
31 Mar 2353,4879,4946,8550
31 Dec 2252,6549,2947,2850
30 Sep 2251,6328,8187,3480
30 Jun 2250,0588,0867,4220
31 Mar 2249,1337,9877,3560
31 Dec 2147,5987,3986,8520
30 Sep 2146,3087,1776,6320
30 Jun 2144,6367,0616,2960
31 Mar 2143,1006,9076,1260
31 Dec 2041,7576,4926,3450
30 Sep 2041,5866,5876,3390
30 Jun 2041,5856,5634,8440
31 Mar 2040,9315,9296,2270
31 Dec 1940,3835,9526,3570
30 Sep 1939,0775,2556,2310
30 Jun 1938,3264,8496,0760
31 Mar 1936,7864,5036,0220
31 Dec 1835,6064,3725,7270
30 Sep 1834,9414,3555,5750
30 Jun 1834,4604,3545,5060
31 Mar 1832,9854,0125,3250
31 Dec 1732,2423,4324,7600
30 Sep 1730,8933,1344,7270
30 Jun 1728,7942,5094,6130
31 Mar 1729,0262,7664,5170
31 Dec 1628,9592,9804,4020
30 Sep 1628,0972,8024,4030
30 Jun 1627,2932,6634,4030
31 Mar 1626,1452,5534,4440
31 Dec 1525,3802,5046,1940
30 Sep 1524,5042,4456,1090
30 Jun 1523,9502,4666,0160
31 Mar 1522,8932,2904,0020
31 Dec 1422,0082,1765,9430
30 Sep 1421,1032,0655,7060
30 Jun 1419,7761,8805,5580
31 Mar 1418,6941,6685,5410
31 Dec 1317,5271,6012,3130
30 Sep 1317,5801,2734,2970

Quality Earnings: 500488 has high quality earnings.

Growing Profit Margin: 500488's current net profit margins (20.5%) are higher than last year (17.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 500488's earnings have grown by 17.5% per year over the past 5 years.

Accelerating Growth: 500488's earnings growth over the past year (26.5%) exceeds its 5-year average (17.5% per year).

Earnings vs Industry: 500488 earnings growth over the past year (26.5%) exceeded the Pharmaceuticals industry 17%.


Return on Equity

High ROE: 500488's Return on Equity (32.5%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.